High pretreatment platelet counts and low pretreatment hemoglobin levels can be negative prognostic factors in patients with ovarian cancer; there was observed the relationship of cystic fluid IL-6 levels with platelet counts and hemoglobin levels [23]. Here, IL6 is linked to ovarian carcinoma.